Literature DB >> 17266084

Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor.

Kimberly M Miller1, Michael S Okun, Hubert F Fernandez, Charles E Jacobson, Ramon L Rodriguez, Dawn Bowers.   

Abstract

Depression is common in Parkinson's disease (PD) and affects 30 to 50% of all patients. In contrast to the wealth of research on depression in PD, little is known about the occurrence of depression in other movement disorders. The primary objective of the current study was to determine whether the high prevalence of depression symptoms seen in PD is also found in other movement disorders, by directly comparing rates of specific depression symptoms and depression severity across PD, dystonia, and essential tremor (ET). Three hundred and fifty-four patients with PD, 83 patients with dystonia, and 53 patients with ET completed the Beck Depression Inventory (BDI). We found no significant between-groups differences for depression severity, frequency, or endorsement of specific depression symptoms. Forty-eight percent of PD patients, 37.3% of dystonia patients, and 34% of ET patients were found to be at least mildly depressed (BDI score of 10 or higher). The most commonly endorsed symptoms were fatigability, difficulty with work, anhedonia, and sleep disturbance. Clinicians should be aware that depression is a frequent problem in dystonia and ET, in addition to PD, and inquire about depression symptoms in these patients so that they can be appropriately treated.

Entities:  

Mesh:

Year:  2007        PMID: 17266084     DOI: 10.1002/mds.21376

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  38 in total

1.  Depressive traits in essential tremor: impact on disability, quality of life, and medication adherence.

Authors:  E D Louis; E D Huey; M Gerbin; A S Viner
Journal:  Eur J Neurol       Date:  2012-05-29       Impact factor: 6.089

Review 2.  Review on clinical update of essential tremor.

Authors:  Wei Chunling; Xiao Zheng
Journal:  Neurol Sci       Date:  2016-01-09       Impact factor: 3.307

3.  Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study.

Authors:  Sebastian Paus; Jennifer Gross; Martina Moll-Müller; Frank Hentschel; Annika Spottke; Bettina Wabbels; Thomas Klockgether; Michael Abele
Journal:  J Neurol       Date:  2011-04-16       Impact factor: 4.849

4.  Essential tremor: is it a neurodegenerative disease? No.

Authors:  Monica M Kurtis
Journal:  J Neural Transm (Vienna)       Date:  2012-08-17       Impact factor: 3.575

5.  Three-dimensional surface mapping of the caudate nucleus in late-life depression.

Authors:  Meryl A Butters; Howard J Aizenstein; Kiralee M Hayashi; Carolyn C Meltzer; Jamie Seaman; Charles F Reynolds; Arthur W Toga; Paul M Thompson; James T Becker
Journal:  Am J Geriatr Psychiatry       Date:  2009-01       Impact factor: 4.105

6.  Impaired heart rate variability in cervical dystonia is associated to depression.

Authors:  F Hentschel; D Dressler; M Abele; S Paus
Journal:  J Neural Transm (Vienna)       Date:  2016-11-05       Impact factor: 3.575

7.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

Review 8.  From neurons to neuron neighborhoods: the rewiring of the cerebellar cortex in essential tremor.

Authors:  Elan D Louis
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

Review 9.  What's new in dystonia?

Authors:  Vicki Shanker; Susan B Bressman
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

10.  Hedonic and behavioral deficits associated with apathy in Parkinson's disease: potential treatment implications.

Authors:  Lizabeth L Jordan; Laura B Zahodne; Michael S Okun; Dawn Bowers
Journal:  Mov Disord       Date:  2013-05-27       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.